Evolus Inc (EOLS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

520 NEWPORT CENTER DRIVE NEWPORT BEACH, CA 92660

Evolus, Inc. operates as a medical aesthetics company. The Company develops, produces, and markets clinical neurotoxins for the treatment of aesthetic, as well as offers regulatory management services. Evolus serves pharmaceutical industry in the United States.

Data as of 2020-05-30
Market Cap154.139 Million Shares Outstanding33.728 Million Avg 30-day Volume1.073 Million
P/E Ratio Dividend Yield EPS-3.37
Price/Sales3.394 Price cash flow ratio Price free cash flow ratio-1.7
Book Value1.86 Price to Tangible Book-10.06 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low20.2689 / 3.115 Stddev
View SEC Filings from EOLS instead.

View recent insider trading info

Funds Holding EOLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EOLS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PARSCHAUER KARAH HERDMAN EVP AND GENERAL COUNSEL

  • Officer
27,312 2020-05-18 3

GILL DAVID N

  • Director
90,000 2020-05-14 2

AVELAR RUI SEE REMARKS

  • Officer
136,802 2020-05-13 4

MOATAZEDI DAVID SEE REMARKS

  • Officer
  • Director
182,070 2020-05-13 2

SILVERNAIL LAUREN P SEE REMARKS

  • Officer
93,388 2020-05-13 2

JAFAR MICHAEL M. CHIEF MARKETING OFFICER

  • Officer
129,000 2020-05-13 2

BLANK SIMONE

  • Director
0 2020-01-23 1

HAU BOSUN

  • Director
0 2020-01-23 1

HAYMAN ROBERT

  • Director
0 2020-01-23 1

MALIK VIKRAM

  • Director
0 2020-01-23 2

ROMINE KRISTINE

  • Director
0 2020-01-23 1

FARRELL PETER C

  • Director
0 2020-01-23 3

AEON BIOPHARMA, INC.

  • FORMER 10% OWNER
0 2020-01-08 3

ALPHAEON 1 LLC

  • 10% Owner
8,662,346 2020-01-08 1

GILL DAVID N

GILL DAVID N

  • Director
0 2019-01-23 2

SILVERNAIL LAUREN P SEE REMARKS

SILVERNAIL LAUREN P SEE REMARKS

  • Officer
0 2019-01-23 2

MALIK VIKRAM

MALIK VIKRAM

  • Director
16,400 2018-12-17 2

JAFAR MICHAEL M. CHIEF MARKETING OFFICER

JAFAR MICHAEL M. CHIEF MARKETING OFFICER

  • Officer
63,000 2018-09-14 2

ROMINE KRISTINE

ROMINE KRISTINE

  • Director
19,360 2018-08-22 1

SIMHAMBHATLA MURTHY V SEE REMARKS

  • Officer
  • Director
100,224 2018-02-07 0

MARMO J CHRISTOPHER CHIEF OPERATING OFFICER

  • Officer
0 2018-02-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MOATAZEDI DAVID - Director - Officer SEE REMARKS

2020-05-13 A 100,000 a 182,070 182,070.00 direct

AVELAR RUI - Officer SEE REMARKS

2020-05-13 A 40,000 a 136,802 136,802.00 direct

SILVERNAIL LAUREN P - Officer SEE REMARKS

2020-05-13 A 40,000 a 93,388 93,388.00 direct

JAFAR MICHAEL M. - Officer CHIEF MARKETING OFFICER

2020-05-13 A 40,000 a 129,000 129,000.00 direct

Elevate your investments